Literature DB >> 16203039

Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.

C H Poh1, H M L Oh, A L Tan.   

Abstract

OBJECTIVE: To determine the epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
MATERIALS AND METHODS: This is a retrospective study on enterococcal bacteraemia in an acute hospital from January 1999 to June 2001. Patients' clinical case notes were reviewed and their demographic, clinical and microbiological data were recorded.
RESULTS: A total of 42 patients (25 males and 17 females) were included in the study, their mean age was 74.8+/-10.9 years. The majority of them had underlying diabetes mellitus and neurological disease. Seventeen patients required intensive care. Sources of enterococcal bacteraemia were identified in 21 cases (urinary tract, 13 patients; hepatobiliary, five; cardiovascular, two and soft tissues, one patient). Eighteen patients had prior invasive procedures. All the Enterococcus species isolated were vancomycin-susceptible; however, eight were ampicillin-resistant and 13 had high-level gentamicin resistance. Shock, disseminated intravascular coagulopathy, acute renal failure and cardiorespiratory arrest occurred in 42% of the cases. Antibiotics were prescribed appropriately in 31 patients and seven deaths were recorded. Of the 11 patients who received inappropriate therapy, six deaths were recorded. Inappropriate antibiotic therapy was associated with mortality. The mortality rate was 31%. Only one patient had a relapse of enterococcal bacteraemia from urinary tract infection secondary to underlying ureteric stricture. There were no vancomycin resistant cases.
CONCLUSION: Urinary tract infection was the most common source of enterococcal bacteraemia. Appropriate antibiotics were essential in treating bacteraemia to reduce mortality. Vancomycin-resistant Enterococcus was not detected. The presence of comorbid conditions and invasive procedures in patients with enterococcal bacteraemia were found in 86 and 71% of patients, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203039     DOI: 10.1016/j.jinf.2005.07.011

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  15 in total

1.  Enterococcal endocarditis: can we win the war?

Authors:  Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Global metabolic response of Enterococcus faecalis to oxygen.

Authors:  Carla A F Portela; Kathleen F Smart; Sergey Tumanov; Gregory M Cook; Silas G Villas-Bôas
Journal:  J Bacteriol       Date:  2014-03-21       Impact factor: 3.490

3.  Antibiotic therapy for Enterococcus bacteraemia: warning for the antimicrobial stewardship team.

Authors:  Bérénice Souhail; Marion Le Maréchal; Roxane Manuello; Ratana Chrétien; Patrick Charlot; Gilles Déroudilhes; Marc Della Guardia; Véronique Blanc; Agnès Fribourg; Nicolas Degand; Pierre-Marie Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-26       Impact factor: 3.267

Review 4.  Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence.

Authors:  Kellie Burnside; Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2011-07       Impact factor: 3.165

5.  Severity of drug resistance and co-existence of Enterococcus faecalis in diabetic foot ulcer infections.

Authors:  Kavitha Shettigar; Deepika V Bhat; Kapaettu Satyamoorthy; Thokur Sreepathy Murali
Journal:  Folia Microbiol (Praha)       Date:  2017-09-09       Impact factor: 2.099

6.  Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.

Authors:  S J McBride; A Upton; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-15       Impact factor: 3.267

7.  Phenotype-Genotype Correlations and Distribution of Key Virulence Factors in Enterococcus faecalis Isolated from Patients with Urinary Tract Infections.

Authors:  Yomna A Hashem; Khaled A Abdelrahman; Ramy K Aziz
Journal:  Infect Drug Resist       Date:  2021-05-10       Impact factor: 4.003

8.  Effect of in-feed administration and withdrawal of tylosin phosphate on antibiotic resistance in enterococci isolated from feedlot steers.

Authors:  Alicia G Beukers; Rahat Zaheer; Shaun R Cook; Kim Stanford; Alexandre V Chaves; Michael P Ward; Tim A McAllister
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

9.  A series of enterococcal brain abscesses.

Authors:  Tanmoy K Maiti; S Nagarathna; H B Veena Kumari; Dhaval P Shukla
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

10.  Virulence, bacterocin genes and antibacterial susceptibility in Enterococcus faecalis strains isolated from water wells for human consumption.

Authors:  Carlos Padilla; Olga Lobos
Journal:  Springerplus       Date:  2013-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.